= Emerging. More than 5 years before clinical availability. (16.60%, 2024)
= Expected to be clinically available in 1 to 4 years. (37.02%, 2024)
= Clinically available now. (46.38%, 2024)
MSACL 2024 : Sani

MSACL 2024 Abstract

Self-Classified Topic Area(s): Other -omics > Cases in Clinical Analysis > Cases of Unmet Clinical Needs

Podium Presentation in Steinbeck 3 on Thursday at 14:45 (Chair: Emma Guiberson / Elizabeth Want)

Cancelled following presenter WD on 3.16. To be replaced by Thomas Horvath on From Mice to Man: Techniques to Surveil Host-Microbe Gut-Brain Interactions
Unveiling the Gut Metabolome: Insights into the Pathogenesis of Necrotising Enterocolitis through Advanced Mass Spectrometry Techniques

Maria Sani (1,2), Kathleen Sim (3), Lauren Ford (1), Alexander Shaw (4), Petra Paizs (1), Simon Kroll (3), James Kinross (2) and Zoltan Takats (1)
(1) Department of Metabolism, Digestion and Reproduction, Imperial College London (UK) (2) Department of Surgery and Cancer, Imperial College London (UK) (3) Faculty of Medicine, Department of Infectious Disease, Imperial College London (UK) (4) Faculty of Medicine, School of Public Health, Imperial College London (UK)

Maria Sani, MSc (Presenter)
Imperial College London

Presenter Bio: Fourth-year PhD student researching neonatology with LCMS metabolomics and lipidomics methods.

Abstract

This abstract has been withdrawn from presentation.

Financial Disclosure

DescriptionY/NSource
Grantsno
Salaryno
Board Memberno
Stockno
Expensesno
IP Royaltyno

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no